Author:
Chatzkel Jonathan,Lewis James S.,Ley Jessica C.,Wildes Tanya M.,Thorstad Wade,Gay Hiram,Daly Mackenzie,Jackson Ryan,Rich Jason,Paniello Randal,Nussenbaum Brian,Liu Jingxia,Siegel Barry A.,Dehdashti Farrokh,Adkins Douglas
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Otorhinolaryngology,Pathology and Forensic Medicine
Reference38 articles.
1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. 2002. CA Cancer J Clin. 2005;55:74.
2. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med. 2001;345:1890–900.
3. Hennessey PT, Westra WH, Califano JA. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res. 2009;88:300–6.
4. Adkins D, Ley J, Trinkaus K, Thorstad W, Lewis J Jr, Wildes T, et al. A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck. Cancer. 2013;119:766–73.
5. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 1998;58:2825–31.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献